Trochlear nerve schwannoma with concomitant osimertinib-responsive stage IV lung adenocarcinoma: illustrative case.

Shunya KashiwagiMasahiro TanjiToshiki MatsuokaNoritaka SanoHiroaki OzasaDaisuke NatoriYasuhide TakeuchiYasuhide MakinoEtsuko Yamamoto HattoriYukinori TeradaYohei MineharuYoshiki Arakawa

Published in: Journal of neurosurgery. Case lessons (2024)

Osimertinib was effective for lung adenocarcinoma but not for trochlear nerve schwannoma, which required surgical intervention. It is necessary to tailor the treatment of benign brain tumors in patients with concurrent malignant cancers. https://thejns.org/doi/10.3171/CASE24144.

Keyphrases

small cell lung cancer
advanced non small cell lung cancer
epidermal growth factor receptor
randomized controlled trial
peripheral nerve
cancer therapy
squamous cell carcinoma
radiation therapy